BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TGRX-1942 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TGRX-1942\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06484816-2765@assetmemo.bio
DTSTAMP:20261121T005451Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:TGRX-1942: Phase 1 readout est. (NCT06484816)
DESCRIPTION:TGRX-1942\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: TGRX-
 1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory H
 ematologic Malignancies\nEstimated primary completion: February 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/tgrx-1942#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT06484816
URL:https://assetmemo.bio/drug/tgrx-1942#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
